Biointron Launches Comprehensive Antibody Developability Assessment Platform to Accelerate Biologic Drug Discovery
Biointron, an antibody contract research organization, launched a new developability platform that helps drug developers identify manufacturing problems early, potentially saving millions by catching issues before late-stage clinical trials. Cambridge, Massachusetts, United States, April 15,… Read More »Biointron Launches Comprehensive Antibody Developability Assessment Platform to Accelerate Biologic Drug Discovery





